Analyst Research

Report Title Price
Provider: Thomson Reuters Stock Report
$25.00
Provider: Wright Reports
$75.00
Provider: Reuters Investment Profile
$20.00
Provider: Thomson Reuters Stock Report
$25.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Chia Jei Technology Business Co Ltd Announces Share Swap of Subsidiary


Friday, 23 Aug 2013 01:54am EDT 

Chia Jei Technology Business Co Ltd announced that Meridigen Biotech Co., Ltd., a biotechnology service provider, will issue 2,500,000 new shares to shareholders of Alarvita Biolife Corporation (Alarvita), which is 95.97% owned by the Company and mainly engaged in the umbilical cord blood storage business, with one share of Alarvita exchanged for 0.8721 share of Meridigen, to acquire a 100% stake (2,866,793 shares) in Alarvita, for resources integration, operation scale expansion and market competitiveness improvement. The expected share swap effective date is August 31, 2013. After that, Alarvita will be no longer a subsidiary of the Company. 

Company Quote

26.2
0.2 +0.77%
24 Apr 2014